First Trust Advisors
AVXL icon

First Trust Advisors’s Anavex Life Sciences AVXL Stock Holding History

First Trust Advisors’s Portfolio AVXL Stock Details AVXL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-177,823
Closed -$4.07M – 2518
2021
Q2 		$4.07M Sell
177,823
-4,966
-3% -$73.6K ﹤0.01% 1476
2021
Q1 		$2.73M Buy
182,789
+37,164
+26% +$406K ﹤0.01% 1602
2020
Q4 		$786K Sell
145,625
-6,582
-4% -$34.7K ﹤0.01% 1988
2020
Q3 		$693K Buy
+152,207
New +$655K ﹤0.01% 1914

Other funds holding AVXL

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
PC
Pier Capital Stamford, Connecticut $606M AUM 63.41% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return